Explain this page
Arphra AIPlain-English read on Viridian Therapeutics, Inc.’s valuation06-05today
- Viridian Therapeutics, Inc. (VRDN) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript7d
- Viridian Metals Commences 2026 Diamond Drill Program at the Kraken7d
- Viridian Metals Commences 2026 Diamond Drill Program at the Kraken7d
- Viridian Metals Highlights Copper-Rich Zones up to 4.15% Cu at Kraken Ahead of 2026 Drill Program11d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $36.86 (+130.66%)
Candlestick · 1Y
Open in chart workstation →VRDN
16.30-50.90%H 34.18L 13.33MA50 20.69MA200 —Avg vol 2.3M
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.96% | +1.46% | -4.99% | -44.46% | -51.35% | -48.65% | +0.25% | -41.08% | -14.41% | -86.02% | -99.22% |
Insider · 30d
History →Bought
$20M
1 txn
Sold
$0
0 txns
Net flow
+$20M
Aftermarket
LiveLast trade
$16.09
5 sh
Bid
$15.70
48 sh
Ask
$16.50
200 sh
Spread
$0.800
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Consumer Defensive+0.72%
- Technology+0.67%
- Real Estate+0.47%
- Energy+0.45%
- Industrials-0.32%
- Financial Services-0.45%
- Utilities-0.49%
- Healthcare-0.92%
- Consumer Cyclical-0.94%
- Basic Materials-1.06%
- Communication Services-1.12%
Top industries (issuer's industry highlighted)
- Biotechnology-0.05%
- Broadcasting-4.30%
- Coal+3.67%
- Hardware, Equipment & Parts-3.62%
- Real Estate - Development-3.31%
- Trucking-3.16%
- Copper-3.02%
- Apparel - Manufacturers-2.63%
- Medical - Equipment & Services-2.31%
- Oil & Gas Energy+2.28%
- Conglomerates-2.28%
- Auto - Dealerships-2.28%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Viridian Therapeutics, Inc. (VRDN) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcriptseekingalpha.com·Jun 10, 2026
- Viridian Metals Commences 2026 Diamond Drill Program at the Krakenglobenewswire.com·Jun 09, 2026
- Viridian Metals Commences 2026 Diamond Drill Program at the Krakenglobenewswire.com·Jun 09, 2026
- Viridian Metals Highlights Copper-Rich Zones up to 4.15% Cu at Kraken Ahead of 2026 Drill Programglobenewswire.com·Jun 05, 2026
- Viridian Metals Highlights Copper-Rich Zones up to 4.15% Cu at Kraken Ahead of 2026 Drill Programglobenewswire.com·Jun 05, 2026
- Viridian Therapeutics Announces Pricing of Upsized Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $350.0 Millionbusinesswire.com·May 06, 2026
- Viridian Therapeutics Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032, Common Stock and Series B Non-Voting Convertible Preferred Stockbusinesswire.com·May 05, 2026
Peers
No peer list available for VRDN.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
Fairmount Funds Management LLC director, 10 percent owner: | Buy | 1M | $20M | May 11, 2026 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|